Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Learn about various ways to make money fast without a job. These quick strategies can help you improve your financial situation!
23,054 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Bitcoin sits at a regulatory crossroads as Consensus 2026 brings renewed debate over the Clarity Act. Hayes argues th...
Bitcoin faces a pivotal crossroad as the 4-year cycle motif intersects ETF-driven demand and the lingering effects of...
Oxbridge Re kicks off 2026 with a Q1 that mixes solid underwriting with measured investment moves. This deep dive exp...
New data from Northwestern Mutual reveals Gen X is running out of time to fund retirement, with a majority unsure abo...
Dogecoin strengthens its footing as ETF inflows stay in positive territory through May, with key resistance near $0.1...
As investors seek simplicity and liquidity in a volatile rate environment, the PIMCO Enhanced Short Maturity Active E...
Ethereum is sliding again as on-chain data show a widening gap between futures bets and spot demand, with dip buyers ...
Two automotive giants draw the attention of investors with shifting revenue engines. This deep dive breaks down Ford ...
The surge in digital payments and online lending has unlocked fresh opportunities in fintech. This guide shows you ho...
As state treasury bills expand into Bitcoin, traders weigh the potential for sustained demand against a capped supply...
Remitly is more than a remittance app. This article dives into why remitly could hidden compounder in cross-border pa...